Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Hankerchiefon Nov 05, 2020 12:45pm

106 Views

Post# 31842689

RE:Listened to 2 PDT talks

enriquesuave wrote: Lilge and Sarah Chamberland. Very good presentations. The animal studies are still ongoing. In vitro they had 100% Tumor cell kill. Animal studies looking good it seems, but still ongoing. Dr Lilge was on ways to achieve proper dosage for Lung cancer Pretty detailed stuff.

.....and Chamberland is using TLD 1433? TIA

Bullboard Posts

Three micro-cap value stocks trading at peak pessimism